Medical News |
- Off-licence recombinant activated factor VII guidelines often ignored
- Stent-assisted coiling of aneurysms lowers recurrence but at cost of more complications
- PSA density effectively predicts Gleason score upgrading after prostate surgery
- <i>BRIP1</i> mutations found in hereditary prostate cancer families
- Tamoxifen following chemotherapy improves breast cancer outcome
- PSA density effectively predicts Gleason score upgrading after prostate surgery
- <i>BRIP1</i> mutations found in hereditary prostate cancer families
- Adiponectin may be marker for metabolic syndrome in menopausal women
- <i>PTPN1</i> variants are associated with high total and LDL cholesterol
- Diabetes impacts myocardial postconditioning success
- Anemia linked to subclinical CVD markers in men with Type 2 diabetes
- Cardiotoxicity of cancer therapies raised again; co-operation of cardiologists and oncologists urged
- Additional antithrombotics increase bleeding risk in MI patients
- Tamoxifen following chemotherapy improves breast cancer outcome
| Off-licence recombinant activated factor VII guidelines often ignored Posted: 10 Dec 2009 04:00 PM PST A study of hospitals in Australia and New Zealand has revealed that although most have guidelines for off-license recombinant activated factor VII use, the majority of patients are not treated in accordance with all elements of the guideline. |
| Stent-assisted coiling of aneurysms lowers recurrence but at cost of more complications Posted: 10 Dec 2009 04:00 PM PST Stent-assisted coiling of intracranial aneurysms is associated with improved angiographic outcomes but also more procedure-related complications compared with stent-free coiling, researchers report. |
| PSA density effectively predicts Gleason score upgrading after prostate surgery Posted: 10 Dec 2009 04:00 PM PST Prostate-specific antigen density significantly predicts Gleason score upgrading in men who are treated with radical prostatectomy for prostate cancer, report researchers. |
| <i>BRIP1</i> mutations found in hereditary prostate cancer families Posted: 10 Dec 2009 04:00 PM PST Researchers have found that men with hereditary prostate cancer have missense, but not protein truncating, variants in the BRIP1 gene. |
| Tamoxifen following chemotherapy improves breast cancer outcome Posted: 10 Dec 2009 04:00 PM PST Addition of chemotherapy to standard tamoxifen treatment for postmenopausal women with node-positive breast cancer significantly improves disease-free survival, and this benefit is maximized when the tamoxifen follows chemotherapy, US researchers report in The Lancet. |
| PSA density effectively predicts Gleason score upgrading after prostate surgery Posted: 10 Dec 2009 04:00 PM PST Prostate-specific antigen density significantly predicts Gleason score upgrading in men who are treated with radical prostatectomy for prostate cancer, report researchers. |
| <i>BRIP1</i> mutations found in hereditary prostate cancer families Posted: 10 Dec 2009 04:00 PM PST Researchers have found that men with hereditary prostate cancer have missense, but not protein truncating, variants in the BRIP1 gene. |
| Adiponectin may be marker for metabolic syndrome in menopausal women Posted: 10 Dec 2009 04:00 PM PST Adiponectin may be a marker for the metabolic syndrome in overweight and obese postmenopausal women with abnormal waist circumferences, say researchers who found low adiponectin levels in this group. |
| <i>PTPN1</i> variants are associated with high total and LDL cholesterol Posted: 10 Dec 2009 04:00 PM PST Three variants in the protein tyrosine phosphatase non-receptor type 1 gene are associated with elevated total and low-density lipoprotein cholesterol in men of normal weight, show study results. |
| Diabetes impacts myocardial postconditioning success Posted: 10 Dec 2009 04:00 PM PST Administration of the volatile anesthetic desflurane on reoxygenation of hypoxic myocardium can provoke a protective postconditioning response even in diabetic patients, a laboratory study indicates. |
| Anemia linked to subclinical CVD markers in men with Type 2 diabetes Posted: 10 Dec 2009 04:00 PM PST Study findings suggest that anemia is associated with an increased cardiovascular risk profile in men with Type 2 diabetes. |
| Cardiotoxicity of cancer therapies raised again; co-operation of cardiologists and oncologists urged Posted: 10 Dec 2009 04:00 PM PST Cardiologists and oncologists should work together to avoid the adverse cardiovascular effects of certain chemotherapies, recommend authors of a review published in the Journal of the National Cancer Institute. |
| Additional antithrombotics increase bleeding risk in MI patients Posted: 10 Dec 2009 04:00 PM PST The risk for bleeding associated with antithrombotic treatment among myocardial infarction patients increases in proportion to the number of antithrombotic drugs used, report researchers in The Lancet. |
| Tamoxifen following chemotherapy improves breast cancer outcome Posted: 10 Dec 2009 04:00 PM PST Addition of chemotherapy to standard tamoxifen treatment for postmenopausal women with node-positive breast cancer significantly improves disease-free survival, and this benefit is maximized when the tamoxifen follows chemotherapy, US researchers report in The Lancet. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment